Is Indivior PLC Ordinary Shares (INDV) overvalued? · P/E 19, rev $1.19B
Indivior PLC Ordinary Shares (INDV) is a drug manufacturers - specialty & generic company listed on NASDAQ.
This page asks whether Indivior PLC Ordinary Shares (INDV) looks expensive on cached numbers — not a short thesis.
Latest reported INDV revenue for 2024-12-31 was $1.19B. Net income was $2.0M. Revenue was up 8.7% from 2023-12-31 to 2024-12-31. INDV currently screens at market cap $4.48B and trailing P/E 19.5.
INDV currently screens at market cap $4.48B and trailing P/E 19.5. A high multiple can be growth prepaid or a bubble. The filing has to explain the gap.
If the next INDV 8-K cuts growth or raises capex, this “expensive” read gets worse. Until then the SEC page is the source.
Not investment advice. Use the INDV stock page for the full model, not this heading.
Not investment advice.